Cole Johnson

Cole Johnson, Ph.D. enthusiastically supports the translation of novel science into meaningful commercial and societal impact. He has held roles in the academic, corporate, and non-profit sectors, namely at the University of Chicago, Baxter, and P33, that all shared a focus on early-stage technology commercialization and open innovation. He enjoys leveraging his network and experiences in corporate innovation, intellectual property management, and new venture strategy to help early deep tech startups increase their likelihood of success. Cole earned a Ph.D. in molecular biology, an MBA and masters and undergraduate degrees in biomedical engineering.